Shares for Interest Debt Settlement
TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX…
TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) — Arch Biopartners Inc., (“Arch” or the “Company”) (TSX…
Quanergy begins trading on the NYSE under Ticker “QNGY” tomorrow, February 9, 2022 Transaction Proceeds…
New infrastructure investments, partnerships address drought and climate change LOS ANGELES–(BUSINESS WIRE)–With extreme drought highlighting…
GE Profile gives consumers smarter technology with new series of top and front load laundry…
NEW YORK–(BUSINESS WIRE)–Silver Spike Investment Corp. (NASDAQ: SSIC), a newly-organized closed-end management investment company that…
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. 08, 2022…
MELBOURNE and LIEGE, Belgium, Feb. 08, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX,…
DUBLIN, Ireland and CHICAGO, Feb. 08, 2022 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
PRINCETON, N.J., Feb. 08, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company,…
IRVINE, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
LEXINGTON, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
BASKING RIDGE, N.J., Feb. 08, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”…
PHILADELPHIA–(BUSINESS WIRE)–Today, Delaware Investments National Municipal Income Fund (NYSE American: VFL) (the “National Muni Fund”)…
OMAHA, Neb.–(BUSINESS WIRE)–Valmont Industries, Inc. (NYSE: VMI), a leading global provider of engineered products and…
Raises 2022 Outlook NASHVILLE, Tenn.–(BUSINESS WIRE)–i3 Verticals, Inc. (Nasdaq: IIIV) (“i3 Verticals” or the “Company”)…
GAITHERSBURG, Md., Feb. 08, 2022 (GLOBE NEWSWIRE) — Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company…
SAN DIEGO, Feb. 08, 2022 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
— Key opinion leaders and patient caregiver to discuss patient experience — — Company to…
CAMBRIDGE, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) — We are advised by ContinuServe that journalists and…